Thermo Fisher Scientific (TMO) offers growth potential with diverse revenue streams, fair valuation, and strong CAGR ...

Liquid Biopsy Market The demand for non-invasive diagnostic techniques is a major driver for the Global Liquid Biopsy <a target=_blank hr ...

Thermo Fisher (TMO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Ameritas Advisory Services LLC reduced its stake in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 19.8% during ...

Thermo Fisher Scientific Inc (TMO) stock saw a decline, ending the day at $559.65 which represents a decrease of $-2.06 or -0.37% from the prior close of $561.71. The stock opened at $562.46 and ...

Thermo Fisher Scientific TMO +0.14% Get Free Report has outperformed the market over the past 15 years by 6.03% on an ...

Thermo Fisher Scientific Inc (TMO) stock saw a decline, ending the day at $551.47 which represents a decrease of $-5.52 or -0.99% from the prior close of $556.99. The stock opened at $557.88 and ...

Novo Holdings, the controlling shareholder of Novo Nordisk , hopes to double the size of its recently acquired contract ...

Thermo Fisher Scientific (NYSE:TMO – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to ...

This important study reveals a role for IκBα in the regulation of embryonic stem cell pluripotency. The solid data in mouse embryonic stem cells include separation of function mutations in IκBα to ...